Chicago, IL, United States of America

Stefani Spranger

USPTO Granted Patents = 6 

 

 

Average Co-Inventor Count = 2.5

ph-index = 1

Forward Citations = 4(Granted Patents)


Location History:

  • Chicago, IL (US) (2016 - 2024)
  • Boston, MA (US) (2024)

Company Filing History:


Years Active: 2016-2024

Loading Chart...
Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Stefani Spranger in Cancer Research

Introduction

Stefani Spranger, based in Chicago, IL, is a renowned inventor with significant contributions in the field of cancer immunotherapy. With a portfolio boasting five patents, she has dedicated her career to developing innovative solutions that address critical challenges in cancer treatment.

Latest Patents

Among her latest patents, the most notable include advancements in the inhibition of β-catenin pathways as a strategy to enhance cancer treatment. The patent titled "Beta-catenin inhibitors in cancer immunotherapy" explores compositions and methods that inhibit β-catenin to prevent or reverse the immune evasion mechanisms exhibited by cancers. Additionally, her patent on the "Synergistic combination of immunologic inhibitors for the treatment of cancer" details methods for treating cancer using combinations of various immunologic inhibitors, including those targeting the PD-L1/PD-1 pathway and others, showcasing her commitment to integrating multifaceted approaches in cancer therapy.

Career Highlights

Stefani has been affiliated with prestigious institutions, including the University of Chicago and Helmholtz Zentrum München Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH). Her work has focused on harnessing the immune system's power to combat cancer, underscoring her role as a leader in immuno-oncology research.

Collaborations

Throughout her career, Stefani has collaborated with other prominent researchers, including Thomas F. Gajewski and Michael Leung. These collaborations have enriched her research and contributed to her success in pioneering new therapeutic approaches for cancer treatment.

Conclusion

Stefani Spranger exemplifies the spirit of innovation in the field of cancer research. Her patents and collaborative efforts are paving the way for more effective cancer therapies, addressing some of the most pressing issues in modern medicine. As she continues her groundbreaking work, the impact of her inventions is sure to resonate in the ongoing battle against cancer.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…